Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Aggregate statistics from Disclosed's verified COA corpus. All numbers are computed directly from lab-uploaded Certificates of Analysis — no editorial claims, no estimates.
COAs
36
Labs
10
2 verified
Vendors tested
19
Avg purity
99.4%
±0.5%
Endotoxin tested
44%
of all COAs tested
Sterility tested
25%
of all COAs tested
Methodology:Purity averages exclude values outside [50%, 100%] to filter unit misreads. "Vendors tested" counts distinct vendor IDs across all in-scope, non-withdrawn, extracted COAs. Endotoxin/sterility coverage denominators are all in-scope COAs (not filtered to parenteral form).
Data updates hourly. All figures are computed from lab-uploaded COAs; Disclosed does not perform independent testing.
Based on 36 Certificates of Analysis in the Disclosed corpus, ARA-290 has an average HPLC purity of 99.4% (±0.5% std dev). This figure spans 19 vendors tested across 10 independent labs. Purity is measured by high-performance liquid chromatography (HPLC); values outside 50–100% are excluded as unit misreads.
10 distinct testing labs have produced COAs for ARA-290 in the Disclosed database, covering 36 total tests across 19 vendors. 2 of those labs have a verified Disclosed partner account, meaning their COAs are uploaded directly by the lab.
44% of ARA-290 COAs in the Disclosed corpus include endotoxin test results (USP <85>), and 25% include sterility results (USP <71>). Endotoxin and sterility testing matter for injectable-grade peptides — their absence in a COA does not indicate failure, but absence is common in HPLC-only testing workflows.
Verified labs with COAs for ARA-290 in the Disclosed corpus include: ILS Labs (grade B, 3 COAs); Ethos Analytics (grade C, 1 COA). These grades reflect Disclosed's credibility scoring of each lab's full COA corpus — purity distribution, safety panel breadth, and verification engagement.
Disclosed Labs